Home » Newsletters » BioWorld

BioWorld

March 31, 1992

View Archived Issues

EPO LIMITED BENEFITS AS SURGERY ADJUNCT

NCI INITIATES TRIAL OF ONCOLYSIN B

FDA APPROVES CHIRON UNIT'S LENS

ENZON TO COLLABORATE WITH CYTOCLONAL

IMRE SPINS OFF A DIAGNOSTIC UNIT

GENSIA OPENS NEW ARASINE TRIALS

ANALYST PREDICTS 2Q REBOUND BY TOP STOCKS

GYNEX TECH EXCHANGE WITH BRISTOL-MYERS

ADVANCED TISSUE PROPOSES $21M ACQUISITION

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026